arrow
C

Catherine H. Régnier

University of Freiburg
H指数:29
被引数:5,023

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

CD40 blockade hampers IgG class-switch while enhancing Granzyme B production by transitional B cells

CD40阻断抑制IgG类别转换,同时增强过渡型B细胞中Granzyme B的产生

2025-01-010
PRE
Discovery and development of ANV419, an IL-2/anti-IL-2 antibody fusion protein with potent CD8+T and natural killer cell-stimulating capacity for cancer immunotherapy

ANV419的发现和开发,一种具有有效CD8 T和自然杀伤细胞刺激能力的IL-2/anti-IL-2抗体融合蛋白,用于癌症免疫治疗

MABS
IF7.3
2024-07-230
OAAI
Single-cell transcriptomic analysis of renal allograft rejection reveals insights into intragraft TCR clonality
2023-07-1713
OAAI
Discovery of Potent, Highly Selective, and In Vivo Efficacious, Allosteric MALT1 Inhibitors by Iterative Scaffold Morphing
2020-11-3018
PREAI
Optimization of the In Vivo Potency of Pyrazolopyrimidine MALT1 Protease Inhibitors by Reducing Metabolism and Increasing Potency in Whole Blood
2020-11-2019
PREAI
Stabilizing Inactive Conformations of MALT1 as an Effective Approach to Inhibit Its Protease Activity
2020-06-174
PREAI
Requirement of Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1 Protease Activity for Fcγ Receptor-Induced Arthritis, but Not Fcγ Receptor-Mediated Platelet Elimination, in Mice
2020-04-269
PREAI
The T-cell fingerprint of MALT1 paracaspase revealed by selective inhibition

通过选择性抑制揭示的MALT1 paracaspase的T细胞指纹

2017-12-2153
OAAI
Deficiency of MALT1 Paracaspase Activity Results in Unbalanced Regulatory and Effector T and B Cell Responses Leading to Multiorgan Inflammation
2015-04-15116
OAAI
Modulation of Activation-Loop Phosphorylation by JAK Inhibitors Is Binding Mode Dependent

JAK抑制剂对激活环磷酸化的调节是结合模式依赖性的

2012-06-07114
OA
Genetic resistance to JAK2 enzymatic inhibitors is overcome by HSP90 inhibition
2012-01-23138
OAAI
Potent and Selective Inhibition of Polycythemia by the Quinoxaline JAK2 Inhibitor NVP-BSK805
2010-07-07113
OAAI
Mutations in components of complement influence the outcome of Factor I-associated atypical hemolytic uremic syndrome

补体成分的突变会影响因子I相关的非典型溶血性尿毒症综合征的结果

2010-02-01159
OAAI